Introducing
First To Know
The new First To Know Syphilis Test is the only over-the-counter test for syphilis that provides accurate in-home results, in minutes.
The First To Know Syphilis Test
Fast
Get results in as little as 15 minutes.
Accurate
Be confident in your result with clinically proven, patented technology.
Simple
Just touch, tap, test for an accurate result in minutes.
Touch. Tap. Test.
It’s that easy.
-
Touch
Stick your finger with the provided lancet and touch the Test to your finger to let 1-3 drops of blood enter the Test.
-
Tap
Tap the Test twice on a table and lay it flat.
-
Test
Wait 15 minutes for your at-home syphilis test result.
Find Out Now
Be the First to Know.
Get the First To Know Syphilis Test online or at a store near you.
What you don’t know can hurt you.
Syphilis has been resurging at an alarming rate.
Approx
Increase in syphilis cases in the U.S. over the last 5 years*
What is syphilis?
Syphilis Resources
Syphilis is a sexually transmitted infection (STI) that can cause serious health problems without treatment. It starts with a small sore around private parts or in the mouth which may not even be noticed.
*U.S. Centers for Disease Control and Prevention
Learn More
In the news
-
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.
Read MoreAs syphilis cases surge nationwide, the collaboration will bring the First To Know over-the-counter test to clinicians and patients across professional and hospital settings NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announced that Labcorp, a global leader of innovative and comprehensive laboratory services, will be the exclusive U.S. distributor…
-
NOWDiagnostics First To Know Syphilis Test Receives FDA De Novo Marketing Authorization for Over-the-Counter Use
Read MoreFirst and only rapid syphilis test with in-home results in minutes, addressing growing epidemic SPRINGDALE, ARK. – August 16, 2024 – NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announced that the U.S. Food and Drug Administration (FDA) has granted marketing authorization to its First To Know® Syphilis Test for…
-
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.
Read MoreAs syphilis cases surge nationwide, the collaboration will bring the First To Know over-the-counter test to clinicians and patients across professional and hospital settings NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announced that Labcorp, a global leader of innovative and comprehensive laboratory services, will be the exclusive U.S. distributor…
-
NOWDiagnostics First To Know Syphilis Test Receives FDA De Novo Marketing Authorization for Over-the-Counter Use
Read MoreFirst and only rapid syphilis test with in-home results in minutes, addressing growing epidemic SPRINGDALE, ARK. – August 16, 2024 – NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announced that the U.S. Food and Drug Administration (FDA) has granted marketing authorization to its First To Know® Syphilis Test for…
-
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.
Read MoreAs syphilis cases surge nationwide, the collaboration will bring the First To Know over-the-counter test to clinicians and patients across professional and hospital settings NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announced that Labcorp, a global leader of innovative and comprehensive laboratory services, will be the exclusive U.S. distributor…
-
NOWDiagnostics First To Know Syphilis Test Receives FDA De Novo Marketing Authorization for Over-the-Counter Use
Read MoreFirst and only rapid syphilis test with in-home results in minutes, addressing growing epidemic SPRINGDALE, ARK. – August 16, 2024 – NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announced that the U.S. Food and Drug Administration (FDA) has granted marketing authorization to its First To Know® Syphilis Test for…
-
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.
Read MoreAs syphilis cases surge nationwide, the collaboration will bring the First To Know over-the-counter test to clinicians and patients across professional and hospital settings NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announced that Labcorp, a global leader of innovative and comprehensive laboratory services, will be the exclusive U.S. distributor…
-
NOWDiagnostics First To Know Syphilis Test Receives FDA De Novo Marketing Authorization for Over-the-Counter Use
Read MoreFirst and only rapid syphilis test with in-home results in minutes, addressing growing epidemic SPRINGDALE, ARK. – August 16, 2024 – NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announced that the U.S. Food and Drug Administration (FDA) has granted marketing authorization to its First To Know® Syphilis Test for…
-
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.
Read MoreAs syphilis cases surge nationwide, the collaboration will bring the First To Know over-the-counter test to clinicians and patients across professional and hospital settings NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announced that Labcorp, a global leader of innovative and comprehensive laboratory services, will be the exclusive U.S. distributor…
-
NOWDiagnostics First To Know Syphilis Test Receives FDA De Novo Marketing Authorization for Over-the-Counter Use
Read MoreFirst and only rapid syphilis test with in-home results in minutes, addressing growing epidemic SPRINGDALE, ARK. – August 16, 2024 – NOWDiagnostics, Inc. (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostic tests, today announced that the U.S. Food and Drug Administration (FDA) has granted marketing authorization to its First To Know® Syphilis Test for…